Literature DB >> 8280854

Prion protein is abnormally accumulated in inclusion-body myositis.

V Askanas1, M Bilak, W K Engel, R B Alvarez, F Tomé, A Leclerc.   

Abstract

In muscle biopsies of 8 sporadic inclusion-body myositis (S-IBM) and 4 hereditary inclusion-body myopathy (H-IBM) patients, vacuolated muscle fibers contained within their vacuoles strongly immunoreactive inclusions with 2 polyclonal and 1 monoclonal antibodies against prion protein (PrP). By light-microscopy, PrP deposits co-localized with beta-amyloid protein (A beta) and ubiquitin (Ub). By immuno-electronmicroscopy, both PrP and A beta were present on amorphous material and on 6-10 nm amyloid-like fibrils; and PrP and Ub co-localized on cytoplasmic twisted tubulofilaments (TTFs) and on amorphous material. Our study provides the first demonstration of abnormally accumulated PrP in pathological tissue other than brain, and it suggests that PrP may play a role in the pathogenesis of IBM.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280854     DOI: 10.1097/00001756-199310000-00006

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.

Authors:  Jingjing Liang; Wei Wang; Debra Sorensen; Sarah Medina; Sergei Ilchenko; Janna Kiselar; Witold K Surewicz; Stephanie A Booth; Qingzhong Kong
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

2.  Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation.

Authors:  G M Wilczynski; W K Engel; V Askanas
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 3.  Etiology and pathogenesis of prion diseases.

Authors:  S J DeArmond; S B Prusiner
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

4.  Muscle fiber degeneration in distal myopathy with rimmed vacuole formation.

Authors:  N Murakami; Y Ihara; I Nonaka
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

5.  Prion infection of muscle cells in vitro.

Authors:  Wendy M Dlakic; Eric Grigg; Richard A Bessen
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

6.  Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.

Authors:  Michael C Sugarman; Tritia R Yamasaki; Salvatore Oddo; Julio C Echegoyen; M Paul Murphy; Todd E Golde; Mehrdad Jannatipour; Malcolm A Leissring; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

7.  Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.

Authors:  L W Jin; M G Hearn; C E Ogburn; N Dang; D Nochlin; W C Ladiges; G M Martin
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy.

Authors:  E Sarkozi; V Askanas; W K Engel
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

9.  Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice.

Authors:  Shenghai Huang; Jingjing Liang; Mengjie Zheng; Xinyi Li; Meiling Wang; Ping Wang; Difernando Vanegas; Di Wu; Bikram Chakraborty; Arthur P Hays; Ken Chen; Shu G Chen; Stephanie Booth; Mark Cohen; Pierluigi Gambetti; Qingzhong Kong
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

10.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.